COMBINED IMMUNOTHERAPY WITH IL12-EXPRESSING DENDRITIC CELLS AND AFP-PULSED DC TOWARDS ESTABLISHED HEPATOCELLULAR CARCINOMA IN VIVO

被引：0
|
作者：
Decker, G. [1 ]
Vogt, A. [1 ]
Raskopf, E. [1 ]
Schmitz, V. [1 ]
Caselmann, W. H. [2 ]
Sauerbruch, T. [1 ]
Gonzalez-Carmona, M. A. [1 ]
机构：
[1] Univ Bonn, D-5300 Bonn, Germany
[2] Bavarian State Minist Environm & Publ Hlth, Munich, Germany
来源：
JOURNAL OF HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
10.1016/S0168-8278(11)60207-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
205
引用
收藏
页码：S87 / S87
页数：1
相关论文
共 47 条
  • [41] Cytotoxicity study of the interleukin-12-expressing recombinant Newcastle disease virus strain, rAF-IL12, towards CT26 colon cancer cells in vitro and in vivo
    Najmuddin, Syed Umar Faruq Syed
    Amin, Zahiah Mohamed
    Tan, Sheau Wei
    Yeap, Swee Keong
    Kalyanasundram, Jeevanathan
    Ani, Muhamad Alhapis Che
    Veerakumarasivam, Abhimanyu
    Chan, Soon Choy
    Chia, Suet Lin
    Yusoff, Khatijah
    Alitheen, Noorjahan Banu
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [42] The effect of immunotherapy based on a combination of modified dendritic cells overproducing IL-12, IL-15 or IL-18 and anti-IL-10R antibodies on the inhibition of tumor growth in MC38 colon carcinoma
    Ciura, Katarzyna Wegierek
    Mierzejewska, Jagoda
    Szczygiel, Agnieszka
    Wroblewska, Anna
    Olearnik, Bozena Szermer
    Rossowska, Joanna
    Piasecka, Elzbieta Pajtasz
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 407 - 407
  • [43] A randomised phase II clinical trial of low-dose cyclophosphamide and transarterial chemoembolization (TACE) with or without vaccination with dendritic cells (DC) pulsed with HepG2 lysate ex vivo in patients with hepatocellular carcinoma (HCC): The ImmunoTACE trial.
    Ting Ma, Yuk
    Kirkham, Amanda
    Curbishley, Stuart
    Rowe, Anna
    Blahova, Miroslava
    Mehrzad, Homoyon
    Karkhanis, Salil
    Punia, Pankaj
    James, Martin
    Rohit Rao, Ankit
    Stern, Nick
    Palmer, Daniel H.
    Hull, Diana
    Lowe, Faye
    Douglas-Pugh, Jessica
    Bathurst, Camilla
    Wilkhu, Manpreet
    Yap, Christina
    Adams, David H.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [44] Optimized biodegradable polymeric reservoir-mediated local and sustained co-delivery of dendritic cells and oncolytic adenovirus co-expressing IL-12 and GM-CSF for cancer immunotherapy
    Oh, Eonju
    Oh, Jung-Eun
    Hong, JinWoo
    Chung, YoonHo
    Lee, Yunki
    Park, Ki Dong
    Kim, Sungwan
    Yun, Chae-Ok
    JOURNAL OF CONTROLLED RELEASE, 2017, 259 : 115 - 127
  • [45] Comprehensive immunotherapy combined with intratumoral injection of zoledronate-pulsed dendritic cells, intravenous adoptive activated T lymphocyte and gemcitabine in unresectable locally advanced pancreatic carcinoma: a phase I/II trial
    Hirooka, Yoshiki
    Kawashima, Hiroki
    Ohno, Eizaburo
    Ishikawa, Takuya
    Kamigaki, Takashi
    Goto, Shigenori
    Takahara, Masashi
    Goto, Hidemi
    ONCOTARGET, 2018, 9 (02) : 2838 - 2847
  • [46] CD40/CD40LIGAND INTERACTION BETWEEN TUMOR LYSATE-PULSED DENDRITIC CELLS INDUCES A TH1-ENVIRONMENT AND ENHANCES THE CYTOTOXIC ACTIVITY OF IMMUNOLOGIC EFFECTOR CELLS TOWARDS HUMAN HEPATOCELLULAR CARCINOMA AND CHOLANGIOCELLULAR CARCINOMA CELLS
    Vogt, A.
    Hillebrand, R. M.
    Raskopf, E.
    Schmidt-Wolf, I. G.
    Strassburg, C. P.
    Gonzalez-Carmona, M. A.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S397 - S397
  • [47] Ten Fold Ex-vivo Expansion of Allostimulatory Dendritic Cells (DC) from Cord Blood by Flt-3 Ligand, GM-CSF, TNF-α, IL-4 and Autologous Plasma: Implications for Strategies for Neonatal Vaccinations and/or Post Cord Blood Transplant Immunotherapy ♦ 1378
    Francisco A Bracho
    Carmella van de Ven
    John X Qian
    Stephen Hou
    Mitchell S Cairo
    Pediatric Research, 1998, 43 (Suppl 4) : 236 - 236
12345